We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Universal Health (UHS) Q2 Earnings Beat Estimates, Up Y/Y
Read MoreHide Full Article
Universal Health Services Inc. (UHS - Free Report) reported second-quarter 2018 adjusted earnings of $2.47 per share, beating the Zacks Consensus Estimate by 3.3%. Moreover, the bottom line improved 27.3% year over year.
Universal Health Services, Inc. Price and EPS Surprise
Net revenues increased 2.6% year over year to $2.68 billion. However, the top line lagged the Zacks Consensus Estimate by 1.3%.
Total operating expenses of $2.4 billion at the end of the second quarter rose 3.3% year over year, mainly due to escalating interest expenses.
Segment Update
Acute Care Hospitals:
Adjusted admissions and adjusted patient days increased 1.9% and 4.7%, respectively, from the prior-year quarter. Net revenues (on a same facility basis) climbed 3.3% in the second quarter, majorly backed by rise in admissions and patient days.
Behavioral Hospitals:
On a same facility basis, adjusted admissions increased 1.2% while adjusted patient days declined 0.3%, both on a year-over-year basis. Net revenues grew 2.8% during the quarter under review on a same facility basis due to rise in segment admissions.
Financial Update
As of Jun 30, 2018, the company had cash and cash equivalents of nearly $76 million, up 3.3% from the level at year-end 2017.
Total assets were $11 billion as of Jun 30, 2018, up 2.9% from the tally as of Dec 31, 2017.
The company’s long-term debt came in at $3.8 billion, up 10.6% from the level at 2017 end.
For the first half of 2018, net cash provided by operating activities totaled $629 million, up 18% year over year.
Buyback Program
During the second quarter, the company repurchased 1.12 million shares worth $129.6 million.
Zacks Rank
Universal Health currently carries a Zacks Rank #4 (Sell).
UnitedHealth Group Incorporated’s (UNH - Free Report) second-quarter bottom line beat estimates on the back of higher revenues and solid performances by both segments in the last reported quarter.
Centene Inc.’s (CNC - Free Report) second-quarter earnings surpassed estimates, majorly driven by solid revenues and membership growth.
Anthem Inc. came up with an earnings beat in the second quarter, riding on a strong medical cost performance.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
Image: Bigstock
Universal Health (UHS) Q2 Earnings Beat Estimates, Up Y/Y
Universal Health Services Inc. (UHS - Free Report) reported second-quarter 2018 adjusted earnings of $2.47 per share, beating the Zacks Consensus Estimate by 3.3%. Moreover, the bottom line improved 27.3% year over year.
Universal Health Services, Inc. Price and EPS Surprise
Universal Health Services, Inc. Price and EPS Surprise | Universal Health Services, Inc. Quote
Net revenues increased 2.6% year over year to $2.68 billion. However, the top line lagged the Zacks Consensus Estimate by 1.3%.
Total operating expenses of $2.4 billion at the end of the second quarter rose 3.3% year over year, mainly due to escalating interest expenses.
Segment Update
Acute Care Hospitals:
Adjusted admissions and adjusted patient days increased 1.9% and 4.7%, respectively, from the prior-year quarter. Net revenues (on a same facility basis) climbed 3.3% in the second quarter, majorly backed by rise in admissions and patient days.
Behavioral Hospitals:
On a same facility basis, adjusted admissions increased 1.2% while adjusted patient days declined 0.3%, both on a year-over-year basis. Net revenues grew 2.8% during the quarter under review on a same facility basis due to rise in segment admissions.
Financial Update
As of Jun 30, 2018, the company had cash and cash equivalents of nearly $76 million, up 3.3% from the level at year-end 2017.
Total assets were $11 billion as of Jun 30, 2018, up 2.9% from the tally as of Dec 31, 2017.
The company’s long-term debt came in at $3.8 billion, up 10.6% from the level at 2017 end.
For the first half of 2018, net cash provided by operating activities totaled $629 million, up 18% year over year.
Buyback Program
During the second quarter, the company repurchased 1.12 million shares worth $129.6 million.
Zacks Rank
Universal Health currently carries a Zacks Rank #4 (Sell).
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Releases From the Medical Sector
UnitedHealth Group Incorporated’s (UNH - Free Report) second-quarter bottom line beat estimates on the back of higher revenues and solid performances by both segments in the last reported quarter.
Centene Inc.’s (CNC - Free Report) second-quarter earnings surpassed estimates, majorly driven by solid revenues and membership growth.
Anthem Inc. came up with an earnings beat in the second quarter, riding on a strong medical cost performance.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>